Metagenomics Market was valued at $176
million in 2017 and is expected to reach $523 million by 2024 at a CAGR of
16.8% during the forecast period. The bioinformatics segment accounted for
one-fifth of the total market share in 2017.
Metagenomics is a
relatively new field, which comprises the analysis of collective genomes of the
members of the microbial community along with studying the interaction of
microbes. In addition, metagenomic technologies enable the study of microbial
communities as entire units without entailing the need of cultivating them. As
non-cultivability and genomic diversity serve as the two major roadblocks in
the advancements of environmental and clinical microbiology, metagenomics has
gained immense traction among healthcare professionals and researchers.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/3724?utm_source=sy
The major companies
profiled in this report include
·
Agilent
Technologies Inc.
·
Enterome SA
·
F. Hoffmann-La
Roche Ltd.
·
Illumina Inc.
·
Oxford Nanopore
Technologies Ltd.
·
Pacific Biosciences
of California Inc.
·
PerkinElmer Inc.
·
Qiagen N.V.
·
Swift Biosciences
Inc.
·
Thermo Fisher
Scientific Inc.
The other players
operating in the global metagenomics market include Siemens AG, ZS Genetics,
Inc., Abbott Laboratories, Beckman Coulter, LI-COR, Genomatix GmbH, Beijing
Genomics Institute, and Pieriandx.
In addition, rise
in technological advancements regarding DNA sequencing is anticipated to drive
the demand for metagenomic studies across the globe. Advancements in the same
are highly focused towards the development of DNA sequencing platforms. Moreover,
considerable expansion of metagenomic applications over the years has
supplemented the market growth. The consumable segment generated the highest
revenue in 2017 and is expected to maintain its dominance throughout the
forecast period. This is attributed to the high adoption of consumables in
pre-sequencing, which is one of the most important steps in the overall
metagenomic sequencing protocol. This step comprises sample preparation, sample
processing, and metagenomic sequencing.
Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/3724?utm_source=sy
The instrument
& software segment is expected to register the highest growth rate during
the forecast period. Several instruments and software are employed across
metagenomic analysis, sequencing, sequence binning, annotation, taxonomic
classification, statistical analysis, and data storage & sharing.
Based on
application, the global metagenomics market is classified into infectious
disease diagnosis, environmental remediation, gut microbe characterization,
biotechnology, biofuel, and agriculture. The gut microbe characterization
segment has dominated the global market in 2017 and is expected to maintain
this dominance throughout the forecast period. Whereas, the infectious disease
diagnosis segment has registered the fastest growth rate throughout the
forecast period. The two common metagenomics methods used in the identification
of infectious disease diagnosis include deep amplicon sequencing and
whole-genome shotgun metagenomics.
Key Findings of the
Metagenomics Market:
- The
sequencing segment accounted for four-fifths of the total market share in
2017.
- The
environmental remediation segment registered the second-highest growth
rate among applications with a CAGR of 17.4% from 2018 to 2024.
- North
America dominated the global metagenomics market, accounting for the
maximum share in 2017, and is expected to retain the same trend during the
forecast period.
- India
has registered the highest growth rate in the Asia-Pacific metagenomics
market with a CAGR of 19.7% during the forecast period.
- Germany
accounted for two-sevenths of the total share in the European metagenomics
market in 2017.
The Asia-Pacific
region is expected to witness the highest growth rate throughout the forecast
period, owing to its high population base, surge in disposable income, and rise
in awareness towards new sequencing technologies. In addition, potential
collaborations between the developed and developing economies working in the
field of microbiome and metagenomics are the key contributors for the market
growth in this region.
No comments:
Post a Comment